StockTipsArenaBeta

BUY Eris Lifesciences Limited — Pawan Maheshwari

BUYEris Lifesciences Limited
Eris Lifesciences share price target & all analyst calls

byPawan MaheshwariHorizon: NA (inferred Swing (≤2wk))8 Sept 2026via CNBC Awaaz.

Entry₹1,320.3Inferred
Target₹1,360
Total upside +3.01% (call closed)
Stop loss₹1,305-1.16% risk
Exit₹1,36011 Sept 2026, 2:05 pm
Target hit+3.01%0.00%upside left
Follow Pawan Maheshwari for new calls(40% target hit, 15 closed calls)Get alertsWatch ERIS for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Sept 2026
5 supporting1 neutral0 opposing
Supports the BUY call (5)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Sept · 4d ago

Eris Lifesciences: லாபத்தில் **73%** அதிரடி வளர்ச்சி - பங்கு முதலீட்டாளர்கள் கவனத்திற்கு!

NewsGoogle News·2 Sept · 1w ago

(opens in new tab)

Eris Lifesciences FY26 Revenue ₹3,129 Cr

NewsGoogle News·2 Sept · 1w ago

(opens in new tab)

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·9 Jul · 2mo ago

Neutral / worth noting (1)

Eris Lifesciences Limited has entered into a term loan agreement with Axis Bank Limited for ₹45,00,00,000. The company stated this is a routine financial adjustment and will not impact the expected Ne

NSE · Agreements·9 Sept · yesterday

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Eris Lifesciences

All analyst calls on Eris Lifesciences

More from Pawan Maheshwari

Every call and its outcome